J2503 — Injection, pegaptanib sodium, 0.3 mg
J2503 is a HCPCS Level II code for injection, pegaptanib sodium, 0.3 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on September 30, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J2503 on September 30, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J2503
- Long descriptor
- Injection, pegaptanib sodium, 0.3 mg
- Short descriptor
- Pegaptanib sodium injection
- Added
- January 1, 2006
- Terminated
- September 30, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J2503
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J2503 is not quite right, the correct code is very often within a few positions of it.
- J2460Injection, oxytetracycline hcl, up to 50 mg
- J2468Injection, palonosetron hydrochloride (posfrea), 25 micrograms
- J2469Injection, palonosetron hcl, 25 mcg
- J2470Injection, pantoprazole sodium, 40 mg
- J2471Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg
- J2472Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg
- J2501Injection, paricalcitol, 1 mcg
- J2502Injection, pasireotide long acting, 1 mg
- J2504Injection, pegademase bovine, 25 iuterminated
- J2505Injection, pegfilgrastim, 6 mgterminated
- J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
- J2507Injection, pegloticase, 1 mg
- J2508Injection, pegunigalsidase alfa-iwxj, 1 mg
- J2510Injection, penicillin g procaine, aqueous, up to 600,000 units
- J2513Injection, pentastarch, 10% solution, 100 mlterminated
- J2515Injection, pentobarbital sodium, per 50 mg
Questions about J2503
What is HCPCS code J2503?
J2503 is a HCPCS Level II code for injection, pegaptanib sodium, 0.3 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J2503?
The CMS HCPCS file marks J2503 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J2503 still valid?
No. J2503 was terminated on September 30, 2025 and should not be used on new claims.